Eric Bartee Selected Research

Eric Bartee Research Topics

18	Neoplasms (Cancer) 01/2022 - 09/2009
6	Infections 12/2020 - 07/2008
6	Myxoma (Myxomas) 01/2019 - 10/2012
4	Multiple Myeloma 04/2016 - 10/2012
2	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2021 - 01/2012
2	Melanoma (Melanoma, Malignant) 12/2020 - 01/2017
2	Residual Neoplasm 01/2016 - 10/2012
2	Virus Diseases (Viral Diseases) 05/2012 - 09/2009
1	Inflammation (Inflammations) 01/2022
1	Vaccinia 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2012
1	Necrosis 09/2009
1	Leukemia 09/2002
1	Kaposi Sarcoma (Kaposi's Sarcoma) 09/2002

4	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2002
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 07/2008
3	EnzymesIBA 12/2020 - 04/2016
3	CytokinesIBA 01/2019 - 09/2009
2	Interleukin-12 (IL 12)IBA 01/2022 - 11/2021
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 01/2017
2	InterferonsIBA 09/2009 - 09/2009
1	Interleukin-23 (Interleukin 23)IBA 11/2021
1	Interleukin-23 Subunit p19IBA 11/2021
1	Eflornithine (Ornidyl)FDA Link 10/2021
1	PolyaminesIBA 10/2021
1	SulfotransferasesIBA 12/2020
1	GlycosaminoglycansIBA 12/2020
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	Antigen Receptors (Antigen Receptor)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2017
1	AntibodiesIBA 01/2017
1	Caspase 8 (Caspase-8)IBA 04/2016
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	Activating Transcription Factor 4IBA 01/2015
1	Bortezomib (Velcade)FDA Link 01/2015
1	Proteasome InhibitorsIBA 01/2015
1	Complex MixturesIBA 10/2012
1	GenisteinIBA 06/2010
1	Tyrosine Kinase InhibitorsIBA 06/2010
1	Interferon-betaIBA 09/2009
1	Antiviral Agents (Antivirals)IBA 09/2009
1	Interferon Type IIBA 07/2008
1	RNA (Ribonucleic Acid)IBA 07/2008
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2008
1	Histocompatibility Antigens Class IIBA 09/2002